UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Gene therapy for sickle cell disease: moving from the bench to the bedside

Blood, 2021-09, Vol.138 (11), p.932-941

2021

Link zum Volltext

Verfügbarkeit prüfen

Engraftment in utero: it's all in the delivery

Blood, 2019-11, Vol.134 (22), p.1889-1890

2019

Link zum Volltext

Verfügbarkeit prüfen

Community voices: broadening participation in Science, Technology, Engineering, Mathematics, and Medicine among persons with disabilities

Nature communications, 2022-12, Vol.13 (1), p.7208-7208, Article 7208

2022

Link zum Volltext

Verfügbarkeit prüfen

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease

Journal of clinical medicine, 2022-07, Vol.11 (13), p.3856

2022

Link zum Volltext

Verfügbarkeit prüfen

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease

Seminars in hematology, 2018-04, Vol.55 (2), p.94-101

2018

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions

Hematology/oncology clinics of North America, 2014-12, Vol.28 (6), p.1171-1185

2014

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists’ practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study

Pediatric blood & cancer, 2021-03, Vol.68 (3), p.e28861-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Characterization of natural killer cells expressing markers associated with maturity and cytotoxicity in children and young adults with sickle cell disease

Pediatric blood & cancer, 2019-05, Vol.66 (5), p.e27601-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Homozygous α‐thalassemia: Challenges surrounding early identification, treatment, and cure

Pediatric blood & cancer, 2017-01, Vol.64 (1), p.151-155

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Nature communications, 2024-04, Vol.15 (1), p.3258-3258

2024

Link zum Volltext

Verfügbarkeit prüfen

Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD

PloS one, 2016, Vol.11 (1), p.e0147059-e0147059

2016

Link zum Volltext

Verfügbarkeit prüfen

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?

British journal of haematology, 2020-05, Vol.189 (3), p.408-423

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Blood advances, 2019-07, Vol.3 (14), p.2057-2068

2019

Link zum Volltext

Verfügbarkeit prüfen

Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.125.e1-125.e9

2023

Link zum Volltext

Verfügbarkeit prüfen

Adoptive T CELL Immunotherapy Restores Targeted Antiviral Immunity in Primary Immunodeficiency Disorders

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB186-AB186

2017

Link zum Volltext

Verfügbarkeit prüfen

Sickle Cell Disease and Hematopoietic Stem Cell Transplantation

1st ed. 2018 edition., 2017

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell Disease

Hematology/oncology clinics of North America, 2014-12, Vol.28 (6), p.1171-1185

2014

Link zum Volltext

Verfügbarkeit prüfen

Complex transfusion issues in pediatric hematopoietic stem cell transplantation

Transfusion medicine reviews, 2016-10, Vol.30 (4), p.202-208

2016

Link zum Volltext

Verfügbarkeit prüfen

Disease Burden and Pre-Transplant Health-Related Quality of Life in Pediatric Sickle Cell Disease Patients Receiving Nonmyeloablative HLA-Identical Sibling Donor Transplantation

Blood, 2021-11, Vol.138 (Supplement 1), p.4073-4073

2021

Link zum Volltext

Verfügbarkeit prüfen

Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced Intensity Conditioning: Results of a Phase I Trial

Biology of blood and marrow transplantation, 2017-09, Vol.23 (9), p.1587-1592

2017

Link zum Volltext

Verfügbarkeit prüfen

Adding Hydroxyurea to Chronic Transfusion for Sickle Cell Anemia Reduces Transfusion Burden: Final Results of the HAT Prospective Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.2036-2036

2021

Link zum Volltext

Verfügbarkeit prüfen

HLA Typing Status of Hospitalized Pediatric Patients with Sickle Cell Disease: Impact of Socioeconomics and an Initiative to Offer Typing to All Patients with Siblings

Blood, 2021-11, Vol.138 (Supplement 1), p.2969-2969

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(113)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Hematology
(46)
Humans
(40)
Sickle Cell Disease
(21)
Transplantation
(21)
Hematopoietic Stem Cell Transplantation
(17)
Male
(17)
Female
(16)
Anemia, Sickle Cell - Therapy
(15)
Immunology
(15)
Child
(14)
Transplantation, Homologous
(13)
Adolescent
(12)
Child, Preschool
(11)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(11)
Infant
(11)
Hematology, Oncology And Palliative Medicine
(10)
Transplantation Conditioning - Methods
(10)
Pediatrics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gene therapy for sickle cell disease: moving from the bench to the bedside

Engraftment in utero: it's all in the delivery

Community voices: broadening participation in Science, Technology, Engineering, Mathematics, and Medicine among persons with disabilities

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease

Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions

Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists’ practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study

Characterization of natural killer cells expressing markers associated with maturity and cytotoxicity in children and young adults with sickle cell disease

Homozygous α‐thalassemia: Challenges surrounding early identification, treatment, and cure

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Adoptive T CELL Immunotherapy Restores Targeted Antiviral Immunity in Primary Immunodeficiency Disorders

Sickle Cell Disease and Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell Disease

Complex transfusion issues in pediatric hematopoietic stem cell transplantation

Disease Burden and Pre-Transplant Health-Related Quality of Life in Pediatric Sickle Cell Disease Patients Receiving Nonmyeloablative HLA-Identical Sibling Donor Transplantation

Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced Intensity Conditioning: Results of a Phase I Trial

Adding Hydroxyurea to Chronic Transfusion for Sickle Cell Anemia Reduces Transfusion Burden: Final Results of the HAT Prospective Trial

HLA Typing Status of Hospitalized Pediatric Patients with Sickle Cell Disease: Impact of Socioeconomics and an Initiative to Offer Typing to All Patients with Siblings

Suchergebnisse filtern